Stock Events

Stock Events

IGC Pharma 

$0.2980
95
-$0.00-0.17% 19:57 Today
+$0.00+0%22:30After hours

Statistics

Day High
0.3
Day Low
0.2959
52W High
0.45
52W Low
0.24
Volume
368,914
Avg. Volume
676,439
Mkt Cap
30.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.03
-0.03
-0.02
-0.02
Expected EPS
-0.02
Actual EPS
N/A

Financials

-545.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.39MRevenue
-7.57MNet Income

Analyst Ratings

6.00Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IGC. It's not an investment recommendation.
Schwab US Dividend Equity
20
SCHD
Apple
16
AAPL
Realty Income
16
O
Microsoft
15
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap211.01M
Corbus Pharmaceuticals develops cannabinoid drugs for treating inflammatory and fibrotic diseases, overlapping with IGC's therapeutic areas.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is a licensed producer and distributor of medical cannabis, competing with IGC in the cannabis product market.
Canopy Growth
CGC
Mkt Cap449.07M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, competing across several of IGC's target markets.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor to IGC in the cannabis industry.
Cronos Group
CRON
Mkt Cap1.25B
Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents, competing with IGC in the global cannabis market.

About

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Show more...
CEO
Ram Mukunda
Employees
70
Country
United States
ISIN
US45408X3089
WKN
000A1T87A

Listings

STU
DE
IGS1.STU
MU
DE
IGS1.MU
F
DE
IGS1.F
XASE
US
IGC

0 Comments

Share your thoughts

FAQ

What is IGC Pharma stock price today?▼
The current price of IGC is $0.30 USD — it has decreased by -0.17% in the past 24 hours. Watch IGC Pharma stock price performance more closely on the chart.
What is IGC Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange IGC Pharma stocks are traded under the ticker IGC.
Is IGC Pharma stock price growing?▼
IGC stock has fallen by -3.87% compared to the previous week, the month change is a +20.16% rise, over the last year IGC Pharma has showed a -31.96% decrease.
What is IGC Pharma market cap?▼
Today IGC Pharma has the market capitalization of 30.81M
When is the next IGC Pharma earnings date?▼
IGC Pharma is going to release the next earnings report on November 18, 2026.
What were IGC Pharma earnings last quarter?▼
IGC earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.02 USD resulting in a -50% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IGC Pharma revenue for the last year?▼
IGC Pharma revenue for the last year amounts to 1.39M USD.
What is IGC Pharma net income for the last year?▼
IGC net income for the last year is -7.57M USD.
How many employees does IGC Pharma have?▼
As of September 04, 2026, the company has 70 employees.
In which sector is IGC Pharma located?▼
IGC Pharma operates in the Health & Wellness sector.
When did IGC Pharma complete a stock split?▼
The last stock split for IGC Pharma was on April 19, 2013 with a ratio of 1:10.
Where is IGC Pharma headquartered?▼
IGC Pharma is headquartered in POTOMAC, United States.